About
Portfolio
News
Contact
Contact us
Join Us
News
News
2022.04.21
Qpex Biopharma Announces Presentation of Clinical Data for Ultra-Broad Spectrum β-lactamas...
2022.04.21
Qpex Biopharma Announces Presentation of Clinical Data for Ultra-Broad Spectrum β-lactamas...
view more
2022.03.30
Qpex Biopharma Announces Publication of Data in Nature Communications on the New Synthetic ...
2022.03.30
Qpex Biopharma Announces Publication of Data in Nature Communications on the New Synthetic ...
view more
2022.03.16
Wugen Announces First Patient Dosed in Phase 1/2 Trial of WU-CART-007 for the Treatmen...
2022.03.16
Wugen Announces First Patient Dosed in Phase 1/2 Trial of WU-CART-007 for the Treatmen...
view more
2022.01.20
Qpex Biopharma Announces Progress on Three Clinical Stage Programs for Antibiotic-Resistan...
2022.01.20
Qpex Biopharma Announces Progress on Three Clinical Stage Programs for Antibiotic-Resistan...
view more
2021.12.09
OncoMyx Closes $50 Million Series B to Advance a Novel Immuno-Oncology Platform that Del...
2021.12.09
OncoMyx Closes $50 Million Series B to Advance a Novel Immuno-Oncology Platform that Del...
view more
2021.10.27
Onchilles Pharma Appoints Christopher Twitty, Ph.D., Chief Scientific Officer
2021.10.27
Onchilles Pharma Appoints Christopher Twitty, Ph.D., Chief Scientific Officer
view more
1
2
3
4
5
6
7
8
...
11
12
2022.04.21
